Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1988 Aug;132(2):239–248.

Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus.

J W Gnann Jr 1, J Ahlmén 1, C Svalander 1, L Olding 1, M B Oldstone 1, J A Nelson 1
PMCID: PMC1880719  PMID: 2840830

Abstract

To determine which cells in kidney grafts are infected with human cytomegalovirus (HCMV) before and after transplantation, kidney specimens were studied by in situ hybridization with 35S-labeled DNA probes representing HCMV immediate-early and late genes. Pretransplantation biopsies and serial posttransplantation biopsies were obtained from 7 renal grafts. All of the transplant recipients were HCMV-seronegative at the time of transplantation and all developed primary HCMV infections. HCMV nucleic acids were not detected in biopsies taken from the healthy donor kidneys before transplantation. However, biopsies taken at various intervals after transplantation showed abundant hybridization with HCMV immediate-early and late gene probes. Virtually all of the hybridizing cells were mononuclear inflammatory cells in the interstitial spaces of the kidney. Occasional hybridization was seen with renal tubular or glomerular cells. No cytomegalic cells were seen. Biopsy specimens taken after systemic anti-HCMV chemotherapy with phosphonoformate showed no uniform reduction in HCMV gene expression. These studies demonstrate that the principal HCMV-infected cells in kidneys of renal transplant patients with primary HCMV infections are infiltrating inflammatory cells.

Full text

PDF
239

Images in this article

244Figure 3
on p.244
245Figure 4
on p.245

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahlmén J., Wijnween A. C., Brynger H., Lycke E. Clinical experiences with phosphonoformate (foscarnet) treatment of viral diseases following renal transplantation. Scand J Urol Nephrol Suppl. 1985;92:41–44. [PubMed] [Google Scholar]
  2. Balfour H. H., Jr, Slade M. S., Kalis J. M., Howard R. J., Simmons R. L., Najarian J. S. Viral infections in renal transplant donors and their recipients: a prospective study. Surgery. 1977 May;81(5):487–492. [PubMed] [Google Scholar]
  3. Betts R. F. Cytomegalovirus infection in transplant patients. Prog Med Virol. 1982;28:44–64. [PubMed] [Google Scholar]
  4. Betts R. F., Freeman R. B., Douglas R. G., Jr, Talley T. E. Clinical manifestations of renal allograft derived primary cytomegalovirus infection. Am J Dis Child. 1977 Jul;131(7):759–763. doi: 10.1001/archpedi.1977.02120200041010. [DOI] [PubMed] [Google Scholar]
  5. Braun R. W., Reiser H. C. Replication of human cytomegalovirus in human peripheral blood T cells. J Virol. 1986 Oct;60(1):29–36. doi: 10.1128/jvi.60.1.29-36.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bruning J. H., Bruggeman C. A., van Boven C. P., van Breda Vriesman P. J. Passive transfer of cytomegalovirus by cardiac and renal organ transplants in a rat model. Transplantation. 1986 Jun;41(6):695–698. doi: 10.1097/00007890-198606000-00005. [DOI] [PubMed] [Google Scholar]
  7. Cappel R., Hestermans O., Toussaint C., Vereerstraeten P., van Beers D., de Braekeleer J., Schoutens E. Cytomegalovirus infection and graft survival in renal graft recipients. Arch Virol. 1978;56(1-2):149–156. doi: 10.1007/BF01317289. [DOI] [PubMed] [Google Scholar]
  8. Demarchi J. M. Human cytomegalovirus DNA: restriction enzyme cleavage maps and map locations for immediate-early, early, and late RNAs. Virology. 1981 Oct 15;114(1):23–38. doi: 10.1016/0042-6822(81)90249-x. [DOI] [PubMed] [Google Scholar]
  9. Fetterman G. H., Sherman F. E., Fabrizio N. S., Studnicki F. M. Generalized cytomegalic inclusion disease of the newborn. Localization of inclusions in the kidney. Arch Pathol. 1968 Jul;86(1):86–94. [PubMed] [Google Scholar]
  10. Fleckenstein B., Müller I., Collins J. Cloning of the complete human cytomegalovirus genome in cosmids. Gene. 1982 Apr;18(1):39–46. doi: 10.1016/0378-1119(82)90054-3. [DOI] [PubMed] [Google Scholar]
  11. Glenn J. Cytomegalovirus infections following renal transplantation. Rev Infect Dis. 1981 Nov-Dec;3(6):1151–1178. doi: 10.1093/clinids/3.6.1151. [DOI] [PubMed] [Google Scholar]
  12. Hall B. M., Bishop G. A., Farnsworth A., Duggin G. G., Horvath J. S., Sheil A. G., Tiller D. J. Identification of the cellular subpopulations infiltrating rejecting cadaver renal allografts. Preponderance of the T4 subset of T cells. Transplantation. 1984 Jun;37(6):564–570. doi: 10.1097/00007890-198406000-00008. [DOI] [PubMed] [Google Scholar]
  13. Hamilton J. D., Seaworth B. J. Transmission of latent cytomegalovirus in a murine kidney tissue transplantation model. Transplantation. 1985 Mar;39(3):290–296. doi: 10.1097/00007890-198503000-00017. [DOI] [PubMed] [Google Scholar]
  14. Hancock W. W., Thomson N. M., Atkins R. C. Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts. Transplantation. 1983 May;35(5):458–463. doi: 10.1097/00007890-198305000-00013. [DOI] [PubMed] [Google Scholar]
  15. Heieren M. H., van der Woude F. J., Balfour H. H., Jr Cytomegalovirus replicates efficiently in human kidney mesangial cells. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1642–1646. doi: 10.1073/pnas.85.5.1642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Helgstrand E., Eriksson B., Johansson N. G., Lannerö B., Larsson A., Misiorny A., Norén J. O., Sjöberg B., Stenberg K., Stening G. Trisodium phosphonoformate, a new antiviral compound. Science. 1978 Sep 1;201(4358):819–821. doi: 10.1126/science.210500. [DOI] [PubMed] [Google Scholar]
  17. Herrera G. A., Alexander R. W., Cooley C. F., Luke R. G., Kelly D. R., Curtis J. J., Gockerman J. P. Cytomegalovirus glomerulopathy: a controversial lesion. Kidney Int. 1986 Mar;29(3):725–733. doi: 10.1038/ki.1986.58. [DOI] [PubMed] [Google Scholar]
  18. Ho M., Suwansirikul S., Dowling J. N., Youngblood L. A., Armstrong J. A. The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med. 1975 Nov 27;293(22):1109–1112. doi: 10.1056/NEJM197511272932201. [DOI] [PubMed] [Google Scholar]
  19. Jahn G., Knust E., Schmolla H., Sarre T., Nelson J. A., McDougall J. K., Fleckenstein B. Predominant immediate-early transcripts of human cytomegalovirus AD 169. J Virol. 1984 Feb;49(2):363–370. doi: 10.1128/jvi.49.2.363-370.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jordan M. C., Shanley J. D., Stevens J. G. Immunosuppression reactivates and disseminates latent murine cytomegalovirus. J Gen Virol. 1977 Nov;37(2):419–423. doi: 10.1099/0022-1317-37-2-419. [DOI] [PubMed] [Google Scholar]
  21. Klotman M. E., Starnes D., Hamilton J. D. The source of murine cytomegalovirus in mice receiving kidney allografts. J Infect Dis. 1985 Dec;152(6):1192–1196. doi: 10.1093/infdis/152.6.1192. [DOI] [PubMed] [Google Scholar]
  22. Lang D. J., Ebert P. A., Rodgers B. M., Boggess H. P., Rixse R. S. Reduction of postperfusion cytomegalovirus-infections following the use of leukocyte depleted blood. Transfusion. 1977 Jul-Aug;17(4):391–395. doi: 10.1046/j.1537-2995.1977.17477216868.x. [DOI] [PubMed] [Google Scholar]
  23. Lopez C., Simmons R. L., Mauer S. M., Najarian J. S., Good R. A., Gentry S. Association of renal allograft rejection with virus infections. Am J Med. 1974 Mar;56(3):280–289. doi: 10.1016/0002-9343(74)90609-3. [DOI] [PubMed] [Google Scholar]
  24. Marker S. C., Howard R. J., Simmons R. L., Kalis J. M., Connelly D. P., Najarian J. S., Balfour H. H., Jr Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants. Surgery. 1981 Jun;89(6):660–671. [PubMed] [Google Scholar]
  25. May A. G., Betts R. F., Freeman R. B., Andrus C. H. An analysis of cytomegalovirus infection and HLA antigen matching on the outcome of renal transplantation. Ann Surg. 1978 Feb;187(2):110–117. doi: 10.1097/00000658-197802000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. McWhinnie D. L., Thompson J. F., Taylor H. M., Chapman J. R., Bolton E. M., Carter N. P., Wood R. F., Morris P. J. Morphometric analysis of cellular infiltration assessed by monoclonal antibody labeling in sequential human renal allograft biopsies. Transplantation. 1986 Oct;42(4):352–358. doi: 10.1097/00007890-198610000-00004. [DOI] [PubMed] [Google Scholar]
  27. Nankervis G. A. Comments on CMV infections in renal transplant patients. Yale J Biol Med. 1976 Mar;49(1):27–28. [PMC free article] [PubMed] [Google Scholar]
  28. Naraqi S., Jackson G. G., Jonasson O., Rubenis M. Search for latent cytomegalovirus in renal allografts. Infect Immun. 1978 Feb;19(2):699–703. doi: 10.1128/iai.19.2.699-703.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Nowak B., Gmeiner A., Sarnow P., Levine A. J., Fleckenstein B. Physical mapping of human cytomegalovirus genes: identification of DNA sequences coding for a virion phosphoprotein of 71 kDa and a viral 65-kDa polypeptide. Virology. 1984 Apr 15;134(1):91–102. doi: 10.1016/0042-6822(84)90275-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Olding L. B., Jensen F. C., Oldstone M. B. Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction. J Exp Med. 1975 Mar 1;141(3):561–572. doi: 10.1084/jem.141.3.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Orsi E. V., Howard J. L., Baturay N., Ende N., Ribot S., Eslami H. High incidence of virus isolation from donor and recipient tissues associated with renal transplantation. Nature. 1978 Mar 23;272(5651):372–373. doi: 10.1038/272372a0. [DOI] [PubMed] [Google Scholar]
  32. Pass R. F., Whitley R. J., Diethelm A. G., Whelchel J. D., Reynolds D. W., Alford C. A., Jr Outcome of renal transplantation in patients with primary cytomegalovirus infection. Transplant Proc. 1979 Jun;11(2):1288–1290. [PubMed] [Google Scholar]
  33. Peterson P. K., Balfour H. H., Jr, Marker S. C., Fryd D. S., Howard R. J., Simmons R. L. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) 1980 Jul;59(4):283–300. [PubMed] [Google Scholar]
  34. Peterson P. K., Ferguson R., Fryd D. S., Balfour H. H., Jr, Rynasiewicz J., Simmons R. L. Infectious diseases in hospitalized renal transplant recipients: a prospective study of a complex and evolving problem. Medicine (Baltimore) 1982 Nov;61(6):360–372. doi: 10.1097/00005792-198211000-00002. [DOI] [PubMed] [Google Scholar]
  35. Porter K. R., Starnes D. M., Hamilton J. D. Reactivation of latent murine cytomegalovirus from kidney. Kidney Int. 1985 Dec;28(6):922–925. doi: 10.1038/ki.1985.218. [DOI] [PubMed] [Google Scholar]
  36. Rice G. P., Schrier R. D., Oldstone M. B. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc Natl Acad Sci U S A. 1984 Oct;81(19):6134–6138. doi: 10.1073/pnas.81.19.6134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Rigby P. W., Dieckmann M., Rhodes C., Berg P. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol. 1977 Jun 15;113(1):237–251. doi: 10.1016/0022-2836(77)90052-3. [DOI] [PubMed] [Google Scholar]
  38. Rubin R. H., Cosimi A. B., Tolkoff-Rubin N. E., Russell P. S., Hirsch M. S. Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation. 1977 Dec;24(6):458–464. doi: 10.1097/00007890-197712000-00010. [DOI] [PubMed] [Google Scholar]
  39. Rubin R. H., Tolkoff-Rubin N. E., Oliver D., Rota T. R., Hamilton J., Betts R. F., Pass R. F., Hillis W., Szmuness W., Farrell M. L. Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation. 1985 Sep;40(3):243–249. doi: 10.1097/00007890-198509000-00004. [DOI] [PubMed] [Google Scholar]
  40. Rüger B., Klages S., Walla B., Albrecht J., Fleckenstein B., Tomlinson P., Barrell B. Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus. J Virol. 1987 Feb;61(2):446–453. doi: 10.1128/jvi.61.2.446-453.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Schrier R. D., Nelson J. A., Oldstone M. B. Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science. 1985 Nov 29;230(4729):1048–1051. doi: 10.1126/science.2997930. [DOI] [PubMed] [Google Scholar]
  42. Simmons R. L., Lopez C., Balfour H., Jr, Kalis J., Rattazzi L. C., Najarian J. S. Cytomegalovirus: Clinical virological correlations in renal transplant recipients. Ann Surg. 1974 Oct;180(4):623–634. doi: 10.1097/00000658-197410000-00028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Smiley M. L., Wlodaver C. G., Grossman R. A., Barker C. F., Perloff L. J., Tustin N. B., Starr S. E., Plotkin S. A., Friedman H. M. The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation. Transplantation. 1985 Aug;40(2):157–161. doi: 10.1097/00007890-198508000-00010. [DOI] [PubMed] [Google Scholar]
  44. Stenberg R. M., Witte P. R., Stinski M. F. Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region 2 and evidence for a common initiation site within immediate-early region 1. J Virol. 1985 Dec;56(3):665–675. doi: 10.1128/jvi.56.3.665-675.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Suwansirikul S., Rao N., Dowling J. N., Ho M. Primary and secondary cytomegalovirus infection. Arch Intern Med. 1977 Aug;137(8):1026–1029. [PubMed] [Google Scholar]
  46. Wathen M. W., Stinski M. F. Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection. J Virol. 1982 Feb;41(2):462–477. doi: 10.1128/jvi.41.2.462-477.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Wiley C. A., Schrier R. D., Denaro F. J., Nelson J. A., Lampert P. W., Oldstone M. B. Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patient. J Neuropathol Exp Neurol. 1986 Mar;45(2):127–139. doi: 10.1097/00005072-198603000-00003. [DOI] [PubMed] [Google Scholar]
  48. Wu B. C., Dowling J. N., Armstrong J. A., Ho M. Enhancement of mouse cytomegalovirus infection during host-versus-graft reaction. Science. 1975 Oct 3;190(4209):56–58. doi: 10.1126/science.170676. [DOI] [PubMed] [Google Scholar]
  49. van Es A., Baldwin W. M., Oljans P. J., Tanke H. J., Ploem J. S., van Es L. A. Expression of HLA-DR on T lymphocytes following renal transplantation, and association with graft-rejection episodes and cytomegalovirus infection. Transplantation. 1984 Jan;37(1):65–69. doi: 10.1097/00007890-198401000-00018. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES